DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...

Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels. But the stock has been performing poorly this year amid ...

Shelomi Sanders, the daughter of Colorado Football head coach Deion Sanders, goes in-depth with Natalie Esquire and ...

DexCom faces significant headwinds, including slower customer growth and increased competition. Learn more on DXCM here.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...